Lupin Limited — Updates, 16-09-2025: General Updates
16-09-2025 | 09:22 pm
16-09-2025 | 09:22 pm
Lupin's Nagpur Injectable facility underwent a US FDA inspection, which concluded with six observations. The company will address these swiftly, reiterating its commitment to CGMP quality standards.
No comments yet. Be the first to comment!
